{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:58:38Z","timestamp":1780941518549,"version":"3.54.1"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"he project of National Natural Science Foundation of China","award":["82060462"],"award-info":[{"award-number":["82060462"]}]},{"name":"Science and Technology Fund Project of Guizhou Provincial Health Commission","award":["gzwjkj2019-1-128"],"award-info":[{"award-number":["gzwjkj2019-1-128"]}]},{"name":"the Project of Scientific and Technological Research of Traditional Chinese Medicine and Ethnic Medicine in Guizhou Province","award":["QZYY-2020-051"],"award-info":[{"award-number":["QZYY-2020-051"]}]},{"name":"Science and Technology Fund Project of Guizhou Provincial Health Commission","award":["gzwjkj2024-390"],"award-info":[{"award-number":["gzwjkj2024-390"]}]},{"name":"Science and Technology Fund Project of Guizhou Provincial Health Commission","award":["gzwjkj2025-329"],"award-info":[{"award-number":["gzwjkj2025-329"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bladder cancer, the most common malignancy of the urinary system, is associated with poor prognosis due to its metastatic potential, invasive behavior, and immune evasion. Intercellular adhesion molecule 5 (ICAM5), a member of the immunoglobulin superfamily, regulates cell adhesion and has been implicated in tumor progression. However, its biological function in bladder cancer remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we analyzed data from The Cancer Genome Atlas (TCGA) and UCSC Xena databases to investigate ICAM5 expression, prognostic significance, genetic mutations, methylation, immune profiles, and regulatory functions in bladder cancer. Weighted Gene Coexpression Network Analysis (WGCNA) and Gene Set Cancer Analysis (GSCA) were employed to explore ICAM5-related pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings demonstrated that ICAM5 expression was significantly upregulated in bladder cancer and associated with advanced disease features, including higher TNM stages, pathological grades, and aggressive molecular subtypes. Furthermore, ICAM5 influenced the immune microenvironment, regulated methylation, and modulated immune checkpoint expression, contributing to immunotherapy resistance. Mechanistically, ICAM5 promoted epithelial-mesenchymal transition (EMT), proliferation, and metastasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ICAM5 serves as a novel prognostic biomarker and potential therapeutic target in bladder cancer, orchestrating EMT progression, reshaping the immune microenvironment, and driving resistance to immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0347623","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:22:30Z","timestamp":1780939350000},"page":"e0347623","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated ICAM5 as a promising predictor of poor prognosis in bladder cancer via EMT, immune microenvironment, and therapy resistance"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-7711","authenticated-orcid":true,"given":"Xiaolong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangsheng","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-3158","authenticated-orcid":true,"given":"Kehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"4","key":"pone.0347623.ref001","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013","volume":"64","author":"M Babjuk","year":"2013","journal-title":"Eur Urol"},{"issue":"2","key":"pone.0347623.ref002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","article-title":"Epidemiology and risk factors of urothelial bladder cancer","volume":"63","author":"M Burger","year":"2013","journal-title":"Eur Urol"},{"issue":"7","key":"pone.0347623.ref003","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s11095-008-9566-7","article-title":"Intravesical treatments of bladder cancer: review","volume":"25","author":"Z Shen","year":"2008","journal-title":"Pharm Res"},{"issue":"5","key":"pone.0347623.ref004","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00262-004-0621-x","article-title":"Immunotherapy for superficial bladder cancer","volume":"54","author":"EAM Schenk-Braat","year":"2005","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"pone.0347623.ref005","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.oraloncology.2005.01.002","article-title":"ICAM-5 (telencephalin) gene expression in head and neck squamous carcinoma tumorigenesis and perineural invasion!","volume":"41","author":"SI Maruya","year":"2005","journal-title":"Oral Oncol"},{"issue":"2","key":"pone.0347623.ref006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/biomedicines10020317","article-title":"A Novel 16-Genes Signature Scoring System as Prognostic Model to Evaluate Survival Risk in Patients with Glioblastoma","volume":"10","author":"Z Yu","year":"2022","journal-title":"Biomedicines"},{"key":"pone.0347623.ref007","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"K Tomczak","year":"2015","journal-title":"Contemporary Oncology (Poznan, Poland)"},{"issue":"2","key":"pone.0347623.ref008","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","article-title":"SnapShot: TCGA-Analyzed Tumors","volume":"173","author":"A Blum","year":"2018","journal-title":"Cell"},{"issue":"21","key":"pone.0347623.ref009","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"T Li","year":"2017","journal-title":"Cancer Res"},{"issue":"7283","key":"pone.0347623.ref010","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"R Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"10364","key":"pone.0347623.ref011","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"E Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"pone.0347623.ref012","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"A Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"issue":"4","key":"pone.0347623.ref013","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.euo.2023.10.003","article-title":"Prognostic Significance of HER2 Expression in Patients with Bacillus Calmette-Gu\u00e9rin-exposed Non-muscle-invasive Bladder Cancer","volume":"7","author":"X Tan","year":"2024","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"pone.0347623.ref014","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s12672-025-02751-5","article-title":"HER2 prognostic values in non-muscle-invasive bladder cancer: a step towards personalized treatment for BCG instillation","volume":"16","author":"X Deng","year":"2025","journal-title":"Discov Oncol"},{"key":"pone.0347623.ref015","article-title":"Global, regional, and national bladder cancer burden from 1990 to 2021 and forecasts to 2050: a systematic analysis of the global disease burden study in 2021","author":"W Feng","year":"2025","journal-title":"BMC Public Health"},{"issue":"23","key":"pone.0347623.ref016","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJM199606063342308","article-title":"Adhesion molecules--Part 1","volume":"334","author":"PS Frenette","year":"1996","journal-title":"New England J Med"},{"issue":"17","key":"pone.0347623.ref017","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0959-8049(02)00218-6","article-title":"Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma","volume":"38","author":"DM O\u2019Hanlon","year":"2002","journal-title":"Eur J Cancer"},{"issue":"3","key":"pone.0347623.ref018","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0896-6273(94)90211-9","article-title":"An ICAM-related neuronal glycoprotein, telencephalin, with brain segment-specific expression","volume":"12","author":"Y Yoshihara","year":"1994","journal-title":"Neuron"},{"issue":"9","key":"pone.0347623.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007012","article-title":"Distinct high-profile methylated genes in colorectal cancer","volume":"4","author":"P Mokarram","year":"2009","journal-title":"PLoS One"},{"issue":"24","key":"pone.0347623.ref020","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.1158\/0008-5472.CAN-04-1788","article-title":"Large-scale association study identifies ICAM gene region as breast and prostate cancer susceptibility locus","volume":"64","author":"S Kammerer","year":"2004","journal-title":"Cancer Res"},{"issue":"1","key":"pone.0347623.ref021","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10142-024-01293-3","article-title":"DNMT1\/DNMT3a-mediated promoter hypermethylation and transcription activation of ICAM5 augments thyroid carcinoma progression","volume":"24","author":"Z Li","year":"2024","journal-title":"Funct Integr Genomics"},{"issue":"22","key":"pone.0347623.ref022","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.3390\/cancers14225538","article-title":"UCHL5 Promotes Proliferation and Migration of Bladder Cancer Cells by Activating c-Myc via AKT\/mTOR Signaling","volume":"14","author":"Y Cao","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"pone.0347623.ref023","doi-asserted-by":"crossref","first-page":"114866","DOI":"10.1016\/j.yexcr.2025.114866","article-title":"Tumor cell exosome circ-0023919 promotes EMT through the miR-197-5p\/ICAM5 axis and enhances the drug resistance of colorectal cancer to 5-fu","volume":"455","author":"J Zhang","year":"2026","journal-title":"Exp Cell Res"},{"issue":"1","key":"pone.0347623.ref024","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13045-022-01307-2","article-title":"Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors","volume":"15","author":"L Xu","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"18","key":"pone.0347623.ref025","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The tumor microenvironment innately modulates cancer progression","volume":"79","author":"DC Hinshaw","year":"2019","journal-title":"Cancer Res"},{"issue":"6","key":"pone.0347623.ref026","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1389450122666211208111833","article-title":"Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid","volume":"23","author":"S Vishwakarma","year":"2022","journal-title":"Curr Drug Targets"},{"issue":"8","key":"pone.0347623.ref027","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Y Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"pone.0347623.ref028","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","article-title":"From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts","volume":"9","author":"L Arpinati","year":"2023","journal-title":"Trends Cancer"},{"issue":"8082","key":"pone.0347623.ref029","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/s41586-025-09303-5","article-title":"NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity","volume":"645","author":"J Heide","year":"2025","journal-title":"Nature"},{"issue":"1","key":"pone.0347623.ref030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"X Chu","year":"2024","journal-title":"Mol Cancer"},{"issue":"7","key":"pone.0347623.ref031","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2007-09-111179","article-title":"Shedded neuronal ICAM-5 suppresses T-cell activation","volume":"111","author":"L Tian","year":"2008","journal-title":"Blood"},{"key":"pone.0347623.ref032","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3389\/fnmol.2017.00431","article-title":"Neuronal ICAM-5 Inhibits Microglia Adhesion and Phagocytosis and Promotes an Anti-inflammatory Response in LPS Stimulated Microglia","volume":"10","author":"S Paetau","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"pone.0347623.ref033","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.2147\/JIR.S475088","article-title":"Involvement of ICAM5 in carcinostasis effects on LUAD Based on the ROS1-related prognostic model","volume":"17","author":"B Liu","year":"2024","journal-title":"J Inflamm Res"},{"issue":"1","key":"pone.0347623.ref034","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1007\/s12672-025-02835-2","article-title":"Identification of therapeutic targets in lung adenocarcinoma using Mendelian randomization and multi-omics","volume":"16","author":"Y Li","year":"2025","journal-title":"Discov Oncol"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347623","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:22:37Z","timestamp":1780939357000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347623"}},"subtitle":[],"editor":[{"given":"Zhengrui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0347623","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}